Kewaunee Scientific Corporation KEQU

FY2026 · ended Apr 30, 2026 · Revenue $282.00M, +17.3% YoY · Filed Jun 26, 2026

Kewaunee Scientific Corporation (KEQU) files with the SEC under industry code 3821, Laboratory Apparatus & Furniture. In fiscal 2026, which ended Apr 30, 2026, it reported revenue of $282.0 million and net income of $9.6 million. Free cash flow was $14.7 million. As of Jul 31, 2026 it held $8.2 million in cash and investments and $28.8 million in total debt.

Revenue (TTM)
$277.21M
+5.3% vs year-ago TTM
Net income (TTM)
$8.23M
-33.1% vs year-ago TTM
Operating cash flow (TTM)
$14.82M
-30.7% vs year-ago TTM
Free cash flow (TTM)
$10.88M
-41.8% vs year-ago TTM
EPS (TTM)
$2.77
-33.0% vs year-ago TTM
Dividend per share
$0.38
-48.6% vs prior year
Shares outstanding
2.87M
+0.9% vs prior year
Net cash
$-20.54M
as of Jul 31, 2026
Operating margin
5.4%
FY 2027

Company profile

Industry
Laboratory Apparatus & Furniture (SIC 3821)
Listed as
KEQU (Nasdaq)
Fiscal year ends
April 30
Incorporated in
DE
Headquarters
Statesville, NC
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
55529

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

Line
FY 2026
Apr 30, 2026
FY 2025
Apr 30, 2025
FY 2024
Apr 30, 2024
FY 2023
Apr 30, 2023
FY 2022
Apr 30, 2022
Revenue
$282.0M
$240.5M
$203.8M
$219.5M
$168.9M
Operating income
$16.7M
$17.8M
$18.3M
$5.4M
-$2.6M
Net income
$9.6M
$11.4M
$18.8M
$738,000
-$6.1M
Diluted EPS
$3.22
$3.83
$6.38
$0.25
-$2.20
Operating cash flow
$18.6M
$14.8M
$19.6M
-$3.8M
-$7.9M
Free cash flow
$14.7M
$12.6M
$15.2M
-$7.9M
-$9.8M
Total assets
$178.3M
$194.7M
$134.8M
$118.9M
$118.8M
Total liabilities
$101.5M
$128.4M
$78.6M
$80.4M
$82.6M
Stockholders' equity
$74.7M
$64.5M
$54.8M
$37.4M
$35.7M
Cash and investments
$9.9M
$14.9M
$23.3M
$8.1M
$4.4M
Total debt
$30.6M
$51.0M
$11.0M
$12.9M
$9.4M

Recent SEC filings

Recent SEC filings
Form Description Filed Period
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Nov 2, 2026 Nov 2, 2026
10-Q Quarterly report Sep 11, 2026 Jul 31, 2026
8-K Current report
Results of operations
Sep 9, 2026 Sep 9, 2026
8-K Current report
Shareholder vote results
Aug 27, 2026 Aug 26, 2026
8-K Current report
Regulation FD disclosure
Aug 26, 2026 Aug 26, 2026
8-K Current report
Other events
Aug 25, 2026 Aug 25, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.